Anebulo Pharmaceuticals, Inc. (214.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 03:29PM CEST. Market open.
| Previous Close | 2.7200 |
| Open | 2.7400 |
| Bid | 2.6200 x N/A |
| Ask | 2.7200 x N/A |
| Day's Range | 2.7400 - 2.7400 |
| 52 Week Range | 1.7100 - 2.7600 |
| Volume | |
| Avg. Volume | 10 |
| Market Cap | 72.601M |
| Beta (5Y Monthly) | -1.00 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3900 |
| Earnings Date | May 09, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.00 |
Simply Wall St.We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Needs To Drive Business Growth Carefully
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Business WireAnebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
AUSTIN, Texas, February 13, 2024--Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
Business WireAnebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
AUSTIN, Texas, November 14, 2023--Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
© 2024 Yahoo. All rights reserved.